VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
Open Access
- 9 February 2009
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 7 (3) , 421-428
- https://doi.org/10.1111/j.1538-7836.2008.03250.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remissionHaematologica, 2008
- ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseasesBlood, 2005
- Binding of ADAMTS13 to von Willebrand FactorJournal of Biological Chemistry, 2005
- von Willebrand factor cleaving protease (ADAMTS‐13) and ADAMTS‐13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2004
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- ADAMTS-13 Metalloprotease Interacts with the Endothelial Cell-derived Ultra-large von Willebrand FactorJournal of Biological Chemistry, 2003
- ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditionsBlood, 2002
- Thrombotic MicroangiopathiesNew England Journal of Medicine, 2002
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.Journal of Clinical Investigation, 1991